India is planning to rein in prices of expensive patented drugs to make medicines affordable to its predominantly poor population, a top government official said on Friday.

Government has deferred decision on Mahindra group's proposal to bring in FDI for a defence production joint venture and on another application by pharma major Pfizer to bring in foreign equity in a c

Biocon and US drug major Pfizer on Tuesday called off USD 350 million global alliance to commercialise the Bangalore-based firm's biosimilar versions of insulin and insulin analog products.

"The comp

Biocon Ltd, India top biotechnology company, reported a 4 per cent drop in quarterly profit due to higher energy costs and rise in wages, but said strong demand from branded formulations offered oppor

Jan. 5: Dr Reddy’s Laboratories (DRL) is likely to contest a patent infringement case filed against it by global pharma giant Pfizer over its cholesterol lowering drug atorvastatin.

Dr Reddy’s had fi